With several new regimens nearing late-stage trials, a new generation of HIV antiretrovirals may soon be entering the marketplace.
ABOUT THIS CONFERENCE: IDWeek 2018 is the seventh annual combined meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS). This year's meeting is being held in San Francisco, Calif., and features some of the latest science and approaches in prevention, diagnosis, treatment and epidemiology of infectious diseases -- including HIV. Please note: TheBodyPRO.com is an independent website not associated with the conference.
TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.